A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate
Clinical trial NCT04192617 · COMPLETED
Trial details
- NCT number
- NCT04192617
- Sponsor
- SinoMab BioScience Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-31
- Primary completion
- 2016-02-03
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.